Geracure Tablet 150 mg (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
MFDS item code 201906391 · Approved 2019.09.10
This product's status changed to Expired on 2024.09.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related diseases (such as ulcers); improvement of gastric mucosal lesions; prevention of Mendelson's syndrome
This medication is used for the treatment of gastrointestinal diseases such as gastric ulcers, duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective for preoperative dosing to prevent Mendelson's syndrome and for treatment of ulcers following surgery. It is utilized for the treatment of gastric and duodenal ulcers resulting from the use of non-steroidal anti-inflammatory drugs (NSAIDs). It helps improve gastric mucosal lesions caused by acute gastritis, acute exacerbation of chronic gastritis, and acute stress ulcers. Additionally, it is used for the treatment of peptic ulcers and acute gastric mucosal lesions caused by upper gastrointestinal bleeding. Overall, it is effective in treating and protecting the gastric mucosa from damage.
Administer 150 mg of ranitidine per dose twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg of this medicine per dose orally twice daily, or 300 mg once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 300 mg per dose twice daily, in the morning and at bedtime. The dosage and administration are the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant treatment to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions generally heal within 4 weeks, and conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Reflux esophagitis: For 8 weeks, administer 150 mg of this medicine per dose twice daily, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg per dose 4 times daily. Zollinger-Ellison syndrome: Start treatment with an initial dose of 150 mg of this medicine per dose 3 times daily and increase as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is generally initiated with an injectable formulation; once oral administration becomes possible, switch to oral administration and administer 150 mg of this medicine per dose twice daily. Premedication for anesthesia (prevention of Mendelson's syndrome): Administer 150 mg of this medicine 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg of this medicine per dose once daily at bedtime. In patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
8 〜 18 years: 150 mg per dose (2 mg per kg of body weight), up to 2 times daily
This medication should not be used in patients with hypersensitivity to any component of the product or a history of acute porphyria. This medicine contains lactose, so patients with genetic problems such as lactose intolerance or galactose intolerance should not take it. Patients with impaired renal function may experience increased blood concentration due to difficulties in drug excretion, necessitating dose adjustment. Patients with impaired liver function should also use this medication cautiously. Patients with a history of drug hypersensitivity or the elderly should use this medication with caution. When taken with non-steroidal anti-inflammatory drugs, especially for the elderly or those with a history of peptic ulcer, regular monitoring is required. This medication may conceal symptoms of gastric cancer, so patients with gastric ulcers or middle-aged patients who recently developed indigestion symptoms should verify malignancy before taking it. Patients with gastric or duodenal ulcers infected with Helicobacter pylori require eradication therapy. During the course of this medication, serious allergic reactions such as anaphylactic shock, urticaria, and angioedema may occur, and if symptoms appear, use should be discontinued immediately. Blood tests may reveal abnormalities such as leukopenia or thrombocytopenia, so symptoms like fatigue, bleeding, or fever should be discussed with healthcare providers. If symptoms of liver dysfunction or jaundice occur, discontinue use immediately and seek medical attention. Neurological side effects such as dizziness, drowsiness, seizures, or confusion may occur, so caution is advised, and use should be stopped if abnormal symptoms arise. Symptoms such as gynecomastia, erectile dysfunction, and decreased libido have been reported rarely, although a clear causal relationship is not established. Musculoskeletal symptoms such as myalgia or rhabdomyolysis may occur, and use should be stopped if symptoms are present. Skin reactions such as rashes or hair loss may occur rarely. Regular blood, liver, and kidney function tests should be conducted to monitor condition while on this medication. If experiencing dizziness or drowsiness, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so any other medications being taken should be reported to healthcare providers. Women who are pregnant or may become pregnant should only take this medication if the benefits outweigh the risks, and it should be used cautiously during breastfeeding. Safety in pediatric patients has not been sufficiently established, so caution is necessary. Elderly patients may experience increased blood concentration due to decreased renal function, so dose adjustments may be required. No specific toxicity has been reported in case of overdose, but symptomatic treatment such as vomiting or gastric lavage may be necessary. This medication should be kept out of the reach of children, and transferring it to another container is not advisable for maintaining quality. Long term use may lead to bacterial overgrowth in the stomach due to decreased gastric acid secretion, so caution is needed. Also, prolonged use may result in abnormalities related to melanin in the eyes, so it is advisable to have ophthalmological examinations.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light. Additionally, for maintaining the drug's effectiveness, it is important to store it at room temperature between 1 degree and 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.